Investors

Date	Name	Title	Type	Shares Traded	Price Range
Nov 2, 2009	brown michael s	Director	Disposition (Non Open Market)	12,000	n/a
Feb 2, 2010	roberts william	Officer	Option Execute	12,000	13.00
Jul 27, 2011	goldberg murray a	Officer	Automatic Sell	12,258	53.18
Feb 2, 2010	kolinski stuart	Officer	Option Execute	12,314	8.50
Apr 30, 2012	aberman michael s	Officer	Option Execute	12,500	24.00
May 13, 2013	aberman michael s	Officer	Option Execute	12,500	24.00
Jun 3, 2010	kolinski stuart	Officer	Option Execute	12,500	8.50
Dec 28, 2009	roberts william	Officer	Automatic Sell	12,500	23.99
Dec 28, 2009	roberts william	Officer	Option Execute	12,500	8.50
Dec 17, 2010	vagelos p roy	Director	Automatic Sell	12,616	32.06
Jan 6, 2011	goldberg murray a	Officer	Automatic Sell	12,627	33.79
Jan 6, 2010	goldberg murray a	Officer	Automatic Sell	12,708	24.76 - 25.06
Oct 10, 2011	terifay robert j	Officer	Automatic Sell	12,786	64.78
Apr 19, 2012	baker charles a	Director	Option Execute	12,910	18.80
Apr 19, 2012	baker charles a	Director	Automatic Sell	12,910	125.00
Nov 5, 2007	brown michael s	Director	Automatic Sell	13,292	20.31 - 20.66
May 6, 2013	tessier-lavigne marc	Director	Sell	13,334	260.20 - 264.17
May 6, 2013	tessier-lavigne marc	Director	Option Execute	13,334	50.91 - 57.11
May 6, 2013	vagelos p roy	Officer	Sell	13,482	263.15 - 264.19
Sep 7, 2011	goldberg murray a	Officer	Automatic Sell	13,531	67.50 - 70.41
Showing 361-380 of 638 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.